RFA-EH-18-000 | RFA EH 18 000

FAQs: RFA-EH-18-000 (CDC/HHS) Type 6 Applications

What is RFA-EH-18-000?

RFA-EH-18-000 is a discretionary federal funding opportunity administered by the U.S. Department of Health and Human Services (HHS) through the Centers for Disease Control and Prevention (CDC). Applications are submitted using the ERA (electronic research administration) system.

What funding mechanism is used for this opportunity?

This opportunity uses a cooperative agreement mechanism. In practical terms, that generally means CDC expects to have substantial involvement in the funded work beyond what would typically occur under a standard grant.

What is the funding activity category?

The funding activity category listed for this opportunity is Health.

What CFDA number is associated with RFA-EH-18-000?

This opportunity is associated with CFDA number 93.136.

What does it mean that this listing is for "Type 6 Applications"?

The listing is presented as a mechanism to submit applications as needed for "Type 6 Applications." In federal assistance terminology, Type 6 commonly refers to supplements or administrative amendments to an existing award rather than a brand-new standalone project application.

Is this an open competitive grant opportunity for new projects?

Based on the information provided, it appears to function less like an open competitive solicitation and more like an administrative portal for existing CDC cooperative agreement recipients (or other specifically eligible entities) to submit Type 6 actions over the open period.

What kinds of requests are typically handled through Type 6 actions?

Type 6 postings like this are often used to support changes or additions to currently funded work, such as expanding the scope within allowable limits, extending or adjusting activities, or requesting additional funds for specific purposes tied to an active cooperative agreement. The precise allowable activities would typically be defined by the underlying award terms, supplemental CDC guidance, and the specific instructions provided to eligible recipients.

Who is eligible to apply?

Eligibility is not broadly defined in the summary fields. The opportunity indicates "Others" and directs applicants to the "Additional Information on Eligibility" section for clarification. This often signals that only certain entities, frequently current recipients or a targeted group identified by CDC, are eligible to submit a Type 6 action.

How can an organization confirm whether it is eligible to submit a Type 6 application?

An organization would generally need to confirm eligibility by reviewing the full notice text (including the referenced eligibility section) and, in many cases, by communicating with the CDC project officer or grants management contacts associated with the existing award.

Which system is used to submit applications?

Applications for this opportunity are submitted through CDC using the ERA (electronic research administration) system.

What are the key dates listed for this opportunity?

The opportunity record shows a creation date of October 20, 2023, and an original closing date of October 13, 2025. This suggests a multi-year window during which Type 6 submissions may be accepted or processed.

Does the long open period mean applications can be submitted at any time?

The dates suggest an extended period for Type 6 submissions, but the exact submission timing and processing expectations would typically be governed by CDC instructions for Type 6 applications, the recipient's award terms, and any program office direction.

How many awards are expected under this listing?

The expected number of awards is listed as 100. This is consistent with a mechanism used to handle many supplemental or amendment actions across multiple recipients.

What is the maximum (ceiling) award amount?

The award ceiling is shown as 0. This commonly indicates that a specific maximum amount is not provided in the public summary and that funding levels may vary by request, be determined case-by-case, or be constrained by the recipient's existing award, program policy, and available appropriations rather than by a single published cap.

Does an award ceiling of 0 mean no funding is available?

Not necessarily. In many federal opportunity summaries, a ceiling of 0 is used when a single public cap is not specified. Actual funding, if available, is typically determined based on the nature of the Type 6 request and constraints tied to the underlying cooperative agreement and available funds.

What role does CDC typically play in a cooperative agreement?

Because this is a cooperative agreement, CDC generally expects substantial involvement in the funded work beyond what would normally occur under a standard grant. The specific nature of that involvement would be defined by the cooperative agreement terms and program guidance.

What information is missing from the brief summary that applicants usually need?

The posted description is described as extremely brief. Details that typically matter for a compliant submission (such as the exact intent, allowable activities, eligibility constraints, and submission instructions) would usually be defined in the underlying award terms, supplemental guidance from the CDC program office, and the specific Type 6 instructions provided to eligible recipients.

What should an applicant align with when preparing a Type 6 submission?

A compliant submission would generally need clear alignment with the terms and objectives of the underlying cooperative agreement associated with CFDA 93.136, along with the CDC instructions applicable to Type 6 applications under this program.

What is the main practical takeaway about RFA-EH-18-000 based on the information provided?

Based on the details provided, RFA-EH-18-000 appears to be primarily an administrative vehicle for eligible CDC cooperative agreement recipients (or other specifically eligible entities) to submit Type 6 supplements or amendments as needed during the open period, rather than a typical open solicitation for brand-new projects.